CLPT
ClearPoint Neuro, Inc. NASDAQ Listed May 22, 2012$17.77
+5.71%
vs $16.81
Mkt Cap $532.9M
52w Low $8.27
43.5% of range
52w High $30.10
50d MA $12.02
200d MA $14.36
P/E (TTM)
-19.7x
EV/EBITDA
—
P/B
18.0x
Debt/Equity
2.1x
ROE
-91.1%
P/FCF
-20.6x
RSI (14)
76.20
ATR (14)
$1.13
Beta
1.18
50d MA
$12.02
200d MA
$14.36
Avg Volume
869.0K
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
120 S. Sierra Avenue · Solana Beach, CA 92075 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | AMC | -0.22 | -0.27 | -22.7% | 11.16 | -4.1% | -13.9% | -4.5% | -1.6% | +5.3% | -0.9% | — |
| Nov 6, 2025 | AMC | -0.20 | -0.21 | -5.0% | 18.23 | -17.9% | -13.3% | +4.6% | +5.3% | -4.0% | -7.2% | — |
| Aug 12, 2025 | AMC | -0.20 | -0.21 | -5.0% | 10.54 | +1.6% | +13.1% | -2.0% | -1.1% | -2.9% | -6.8% | — |
| May 13, 2025 | AMC | -0.15 | -0.22 | -46.7% | 14.20 | -12.0% | -12.5% | +3.9% | +2.0% | -0.5% | -2.5% | — |
| Feb 26, 2025 | AMC | -0.15 | -0.20 | -33.3% | 17.22 | -7.1% | -17.5% | +2.2% | -6.7% | -1.0% | +5.7% | — |
| Nov 7, 2024 | AMC | -0.17 | -0.18 | -5.9% | 13.42 | -6.8% | -13.2% | -2.1% | -2.5% | -1.5% | +2.6% | — |
| Aug 7, 2024 | AMC | -0.19 | -0.16 | +15.8% | 6.44 | +19.4% | +40.7% | -2.0% | +10.1% | +1.3% | -0.8% | — |
| May 7, 2024 | AMC | -0.19 | -0.16 | +15.8% | 5.89 | +9.5% | +1.7% | +2.0% | -4.1% | -0.2% | +2.7% | — |
| Mar 12, 2024 | AMC | -0.22 | -0.19 | +13.6% | 6.05 | +12.6% | +18.5% | +0.6% | -0.8% | -1.1% | -1.3% | — |
| Nov 9, 2023 | AMC | -0.25 | -0.20 | +20.0% | 5.42 | -1.8% | -17.7% | +2.5% | +10.3% | -2.0% | +6.5% | — |
| Aug 8, 2023 | AMC | -0.18 | -0.29 | -61.1% | 6.40 | +0.0% | -2.8% | -1.3% | -2.8% | +3.7% | -3.1% | — |
| May 11, 2023 | AMC | -0.18 | -0.23 | -27.8% | 9.10 | -4.1% | -1.6% | +0.1% | -2.1% | +0.2% | -4.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 8 | Stifel | Reiterates | Buy | $16 | $11.68 | $11.81 | +1.1% | +9.8% | -4.0% | +2.7% | -3.6% | +4.8% |
| Mar 18 | B. Riley Securities | Maintains | Buy → Buy | — | $11.16 | $10.70 | -4.1% | -13.9% | -4.5% | -1.6% | +5.3% | -0.9% |
| Mar 5 | B. Riley Securities | Maintains | Buy → Buy | — | $8.94 | $8.99 | +0.6% | +3.5% | +8.1% | +15.4% | -1.9% | +2.7% |
| Aug 1 | Stifel | Maintains | Buy → Buy | — | $10.40 | $10.12 | -2.7% | -3.8% | +5.3% | +0.0% | +2.5% | +1.2% |
| Apr 25 | B. Riley Securities | Maintains | Buy → Buy | — | $14.29 | $14.34 | +0.3% | +2.9% | +0.1% | -0.3% | -1.9% | -3.3% |
| Apr 1 | Stifel | Maintains | Buy → Buy | — | $11.89 | $12.17 | +2.4% | +10.1% | +0.0% | -7.3% | -9.1% | -0.7% |
| Jan 28 | B. Riley Securities | Maintains | Buy → Buy | — | $17.00 | $17.82 | +4.8% | +5.5% | -0.8% | -1.0% | -0.9% | -2.9% |
| Jan 21 | Lake Street | Maintains | Buy → Buy | — | $15.04 | $16.00 | +6.4% | +22.5% | -2.7% | -0.8% | +0.4% | -4.8% |
| Aug 27 | Lake Street | Maintains | Buy → Buy | — | $11.70 | $12.14 | +3.8% | +9.0% | -1.5% | +4.9% | -1.5% | -2.8% |
| Mar 13 | Stifel | Maintains | Buy → Buy | — | $6.05 | $6.81 | +12.6% | +18.5% | +0.6% | -0.8% | -1.1% | -1.3% |
| Aug 9 | Lake Street | Maintains | Buy → Buy | — | $6.40 | $6.40 | +0.0% | -2.8% | -1.3% | -2.8% | +3.7% | -3.1% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Richards Timothy T. | — | Sell | 5,415 | $12.17 | $66K | 87,198 | +7.52% | +1.57% |
| May 21, 2026 | Klein Matthew B. | — | Sell | 16,000 | $11.59 | $185K | 46,935 | -2.71% | -2.14% |
| May 20, 2026 | FALLON LYNNETTE C | — | Sell | 5,091 | $11.14 | $57K | 48,227 | -2.22% | +3.51% |
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Clearpoint Health (CLPT) disclosed material information via press release and investor presentation on March 17, 2026, potentially signaling major business updates or earnings guidance that could significantly impact stock valuation and investor sentiment.
Mar 17
8-K
ClearPoint Neuro, Inc. -- 8-K Filing
ClearPoint Neuro completed an acquisition and is filing financial statements of the acquired business, indicating the company is expanding its neurotech portfolio through an M&A transaction.
Feb 5
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 1,243,615 | $11M | New | Mar 2026 |
| 2 | Lane Generational Llc | 486,849 | $4M | Added | Mar 2026 |
| 3 | Ubs Group Ag | 432,360 | $4M | Added | Mar 2026 |
| 4 | Sg Americas Securities, Llc | 372,356 | $3M | New | Mar 2026 |
| 5 | Morgan Stanley | 225,292 | $3M | Reduced | Dec 2025 |
| 6 | Vanguard Portfolio Management Llc | 284,809 | $3M | New | Mar 2026 |
| 7 | Prescott Group Capital Management, L.l.c. | 180,525 | $2M | New | Dec 2025 |
| 8 | Millennium Management | 231,974 | $2M | Reduced | Mar 2026 |
| 9 | Parsons Capital Management Inc/ri | 147,186 | $2M | Added | Dec 2025 |
| 10 | Two Sigma Investments, Lp | 210,780 | $2M | Reduced | Mar 2026 |
| 11 | Northern Trust Corp | 209,426 | $2M | Added | Mar 2026 |
| 12 | Tudor Investment Corp | 156,971 | $1M | New | Mar 2026 |
| 13 | Bank Of New York Mellon Corp | 143,747 | $1M | Added | Mar 2026 |
| 14 | Susquehanna International Group, Llp | 136,284 | $1M | Reduced | Mar 2026 |
| 15 | Taylor Frigon Capital Management Llc | 131,901 | $1M | — | Mar 2026 |
| 16 | Cm Management, Llc | 80,000 | $1M | — | Dec 2025 |
| 17 | Financial Engines Advisors L.l.c. | 105,033 | $956K | — | Mar 2026 |
| 18 | Commonwealth Equity Services, Llc | 65,557 | $897K | Added | Dec 2025 |
| 19 | Firstwave Capital Management Llc | 95,840 | $872K | Reduced | Mar 2026 |
| 20 | Bank Of America Corp /de/ | 66,075 | $601K | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$532.9M
Enterprise Value
$506.3M
P/E (TTM)
-19.74x
Forward P/E
—
PEG Ratio
-0.53x
P/B
17.96x
P/S
13.61x
P/FCF
-20.58x
EV/EBITDA
—
Shares Out
28.3M
Financials (TTM)
Revenue
$37.0M
Net Income
-$25.5M
EBITDA
-$21.9M
Free Cash Flow
-$24.4M
Op Cash Flow
-$23.9M
EPS Basic
$-0.90
EPS Diluted
$-0.90
EPS Forward
$-0.97
Gross Margin
61.4%
Op Margin
-65.4%
Net Margin
-69.1%
Balance Sheet
Total Assets
$97.7M
Total Liab.
$69.7M
Total Equity
$28.0M
Cash
$45.9M
LT Debt
$49.1M
Book Value/Sh
$0.99
Debt/Equity
2.08x
Current Ratio
5.91
Quick Ratio
5.13
Returns & Growth
ROE
-91.1%
ROA
-26.1%
ROIC
-27.6%
Rev Growth YoY
+17.8%
EPS Growth YoY
-28.6%
Price Returns
2W
-0.8%
1M
+13.3%
3M
+0.8%
6M
-12.4%
12M
+7.3%
Technicals
52W High
$30.10
52W Low
$8.27
50d MA
$12.02
200d MA
$14.36
RSI (14)
76.20
ATR (14)
$1.13
Beta
1.18
Avg Volume
869K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$18.00
High
$30.00
Low
$9.00
Median
$15.00
Data updated apr 25, 2026 1:46am
· Source: financialmodelingprep.com